Tumor Antivascular Effects of Radiotherapy Combined with Combretastatin A4 Phosphate in Human Non-Small-Cell Lung Cancer

Article ID	Journal	Published Year	Pages	File Type
8242791	International Journal of Radiation OncologyBiologyPhysics	2007	6 Pages	PDF

Abstract

Conclusion: Radiotherapy enhances the tumor antivascular activity of CA4P in human non-small-cell lung cancer, resulting in sustained tumor vascular shutdown.

Keywords

Functional imaging computed tomography Radiotherapy Non–small-cell lung cancer Vascular disrupting agent

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Tumor Antivascular Effects of Radiotherapy Combined with Combretastatin A4 Phosphate in Human Non-Small-Cell Lung Cancer

Authors

Quan-Sing M.B.B.S., M.R.C.P., Vicky M.A., M.R.C.P., F.R.C.R., Dawn M.R.C.P., F.R.C.R., Khalda R.G.N., Anwar R. F.R.C.P., F.R.C.R., Michele I. M.D., F.R.C.P., F.R.C.R., Peter J. M.D., F.R.C.P., F.R.C.R.,